Suja Life Reports Q1 Revenue Growth of 22.5%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 09 2026
0mins
Source: seekingalpha
- Strong Revenue Performance: Suja Life's Q1 revenue reached $107.1 million, reflecting a 22.5% year-over-year increase and exceeding market expectations by $1.11 million, indicating robust demand and growth potential in the health beverage sector.
- Gross Margin Improvement: The gross profit margin increased from 49.8% to 50.5%, showcasing the company's success in cost control and pricing strategies, which further enhances profitability.
- Significant Adjusted EBITDA Growth: Adjusted EBITDA surged 66.3% to $25 million, with adjusted EBITDA margins rising to 23.4% from 17.2% year-over-year, demonstrating a notable improvement in operational efficiency.
- Optimistic Future Outlook: Projected net sales for 2025 are expected to range between $367 million and $371 million, representing a growth of 12.4% to 13.6% compared to last year, while adjusted EBITDA is anticipated to reach $70 million to $72 million, reflecting a growth rate of 72.8% to 77.7%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SUJA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SUJA
Wall Street analysts forecast SUJA stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 9.220
Low
Averages
High
Current: 9.220
Low
Averages
High
About SUJA
Suja Life, Inc. is a beverage platform. The Company operates at the intersection of health, taste, and trust, offering cold-pressed juices, wellness shots, and functional sodas that have become an essential part of consumers' everyday routines. Its brands include Suja Organic, Vive Organic, and Slice. Suja Organic is its flagship brand, known for its organic cold-pressed juices and wellness shots.it includes a green juice platform, boosted juice platform, refreshers platform, and wellness shots platform. Vive Organic is a wellness shot brand, known for the functional shot category with its doctor-crafted formulations and redefining how consumers approach proactive wellness. It offers an immunity boost platform, energy boost platform, and pure boost platform. Slice offers an original better-for-you soda, made with 10% real fruit juice and also with prebiotics, probiotics, postbiotics, reduced sugar, and no artificial ingredients.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Suja Life Reports Q1 Revenue Growth of 22.5%
- Strong Revenue Performance: Suja Life's Q1 revenue reached $107.1 million, reflecting a 22.5% year-over-year increase and exceeding market expectations by $1.11 million, indicating robust demand and growth potential in the health beverage sector.
- Gross Margin Improvement: The gross profit margin increased from 49.8% to 50.5%, showcasing the company's success in cost control and pricing strategies, which further enhances profitability.
- Significant Adjusted EBITDA Growth: Adjusted EBITDA surged 66.3% to $25 million, with adjusted EBITDA margins rising to 23.4% from 17.2% year-over-year, demonstrating a notable improvement in operational efficiency.
- Optimistic Future Outlook: Projected net sales for 2025 are expected to range between $367 million and $371 million, representing a growth of 12.4% to 13.6% compared to last year, while adjusted EBITDA is anticipated to reach $70 million to $72 million, reflecting a growth rate of 72.8% to 77.7%.
See More
Slice Launches New Pineapple Soda, Combining Health and Flavor
- New Product Launch: Slice Soda's latest Pineapple flavor is now available at Albertsons nationwide, marking a significant expansion in the brand's health-focused beverage offerings to meet consumer demand for healthier options.
- Nutritional Profile: Each can contains just 35 calories and 5 grams of sugar, with no high fructose corn syrup or artificial ingredients, showcasing Slice's commitment to health-conscious consumers and appealing to the wellness market.
- Functional Beverage: The Pineapple Soda features a blend of prebiotics, probiotics, and postbiotics aimed at supporting gut health, enhancing the product's competitive edge in the functional beverage sector and catering to consumer preferences for health benefits.
- Brand Positioning: By introducing the Pineapple flavor, Slice Soda reinforces its image as a leader in the healthy beverage space, likely attracting more health-conscious consumers and driving sales growth in a competitive market.
See More
Slice Soda Launches New Pineapple Flavor
- New Flavor Launch: Slice Soda has introduced its new Pineapple flavor, now available at Albertsons nationwide, aimed at attracting health-conscious consumers and further diversifying its product lineup.
- Healthy Ingredients: Each can of Pineapple Soda contains only 35 calories and 5 grams of sugar, with no high fructose corn syrup or artificial ingredients, meeting modern consumer demands for healthier beverage options and enhancing brand appeal.
- Market Positioning: The launch of the Pineapple flavor not only enriches Slice's product portfolio but also satisfies consumer expectations for traditional soda taste through its high carbonation level, thereby boosting market competitiveness.
- Brand Background: Owned by Suja Life, Slice Soda is committed to providing healthy beverages with a unique blend of prebiotics, probiotics, and postbiotics, showcasing the brand's innovation and leadership in the healthy beverage sector.
See More
May IPO Market Rebounds with $11.5 Billion Raised
- Record Fundraising: Thirteen IPOs raised a total of $11.5 billion in May, marking the highest monthly proceeds since November 2021, indicating a robust market recovery and renewed investor confidence.
- Large Deals Dominate: AI chipmaker Cerebras led the market with a $5.6 billion deal, while geothermal energy developer Fervo and data center REIT Blackstone Digital Infrastructure Trust also raised over $1 billion each, highlighting strong demand in AI-related sectors.
- Strong IPO Performance: Traditional IPOs averaged a 5% return from their offer prices, with about half closing above their issue prices, reflecting positive market sentiment towards new listings, particularly with Fervo and BXDC showing strong first-day gains.
- Optimistic Future Outlook: With new filings from companies like SpaceX, more IPO transactions are expected in the coming months as the market broadens, and strong returns alongside a solid pipeline set the stage for a busy IPO calendar ahead.
See More
Latest Rating Changes on Wall Street
- Executive Rating Updates: Goldman Sachs initiates coverage on HawkEye 360 with a Buy rating, emphasizing its status as a profitable RF signals intelligence satellite operator, which is expected to achieve substantial revenue and earnings growth, reflecting strong confidence in its market potential.
- Dell Rating Upgrade: Morgan Stanley upgrades Dell from Underweight to Equal Weight, admitting prior market expectations were incorrect, highlighting Dell's superior supply chain management and execution compared to peers, enabling effective capture of critical demand and market share gains.
- MedTech Company Upgrade: Wells Fargo upgrades Tandem Diabetes Care to Overweight, citing an attractive risk/reward profile in the medical technology sector, indicating optimism about its future growth potential.
- Microsoft Market Performance Initiation: Citizens initiates Microsoft with a Market Outperform rating and a $550 price target, reflecting strong market performance potential despite a 7% decline year-to-date, indicating resilience in its business model.
See More
Suja Life Receives Bullish Ratings After IPO Quiet Period
- Wall Street Bullish Ratings: Suja Life (SUJA) received a clean sweep of bullish ratings from Wall Street after the IPO quiet period ended, with Goldman Sachs issuing a Buy rating and a price target of $31, reflecting strong market confidence in its growth potential.
- New Growth Vector in Functional Beverages: Jefferies analyst noted that juice is being reframed around functional benefits and convenient formats, creating a new growth vector within a $19 billion category, positioning Suja Life favorably as distribution expands and multipacks grow.
- Valuation Advantage: Gajrawala highlighted that Suja Life trades at a valuation of 13X the 2027 EBITDA estimate, which is a discount compared to high-growth peers, indicating its competitive edge and attractiveness in the market.
- Strong Market Performance: Shares of Suja Life (SUJA) jumped 6.9% in premarket trading to $16.50, approaching the IPO price of $21, demonstrating investor optimism regarding its future development.
See More
Suja Life Reports Q1 Revenue Growth of 22.5%
- Strong Revenue Performance: Suja Life's Q1 revenue reached $107.1 million, reflecting a 22.5% year-over-year increase and exceeding market expectations by $1.11 million, indicating robust demand and growth potential in the health beverage sector.
- Gross Margin Improvement: The gross profit margin increased from 49.8% to 50.5%, showcasing the company's success in cost control and pricing strategies, which further enhances profitability.
- Significant Adjusted EBITDA Growth: Adjusted EBITDA surged 66.3% to $25 million, with adjusted EBITDA margins rising to 23.4% from 17.2% year-over-year, demonstrating a notable improvement in operational efficiency.
- Optimistic Future Outlook: Projected net sales for 2025 are expected to range between $367 million and $371 million, representing a growth of 12.4% to 13.6% compared to last year, while adjusted EBITDA is anticipated to reach $70 million to $72 million, reflecting a growth rate of 72.8% to 77.7%.
See More
Slice Launches New Pineapple Soda, Combining Health and Flavor
- New Product Launch: Slice Soda's latest Pineapple flavor is now available at Albertsons nationwide, marking a significant expansion in the brand's health-focused beverage offerings to meet consumer demand for healthier options.
- Nutritional Profile: Each can contains just 35 calories and 5 grams of sugar, with no high fructose corn syrup or artificial ingredients, showcasing Slice's commitment to health-conscious consumers and appealing to the wellness market.
- Functional Beverage: The Pineapple Soda features a blend of prebiotics, probiotics, and postbiotics aimed at supporting gut health, enhancing the product's competitive edge in the functional beverage sector and catering to consumer preferences for health benefits.
- Brand Positioning: By introducing the Pineapple flavor, Slice Soda reinforces its image as a leader in the healthy beverage space, likely attracting more health-conscious consumers and driving sales growth in a competitive market.
See More
Slice Soda Launches New Pineapple Flavor
- New Flavor Launch: Slice Soda has introduced its new Pineapple flavor, now available at Albertsons nationwide, aimed at attracting health-conscious consumers and further diversifying its product lineup.
- Healthy Ingredients: Each can of Pineapple Soda contains only 35 calories and 5 grams of sugar, with no high fructose corn syrup or artificial ingredients, meeting modern consumer demands for healthier beverage options and enhancing brand appeal.
- Market Positioning: The launch of the Pineapple flavor not only enriches Slice's product portfolio but also satisfies consumer expectations for traditional soda taste through its high carbonation level, thereby boosting market competitiveness.
- Brand Background: Owned by Suja Life, Slice Soda is committed to providing healthy beverages with a unique blend of prebiotics, probiotics, and postbiotics, showcasing the brand's innovation and leadership in the healthy beverage sector.
See More
May IPO Market Rebounds with $11.5 Billion Raised
- Record Fundraising: Thirteen IPOs raised a total of $11.5 billion in May, marking the highest monthly proceeds since November 2021, indicating a robust market recovery and renewed investor confidence.
- Large Deals Dominate: AI chipmaker Cerebras led the market with a $5.6 billion deal, while geothermal energy developer Fervo and data center REIT Blackstone Digital Infrastructure Trust also raised over $1 billion each, highlighting strong demand in AI-related sectors.
- Strong IPO Performance: Traditional IPOs averaged a 5% return from their offer prices, with about half closing above their issue prices, reflecting positive market sentiment towards new listings, particularly with Fervo and BXDC showing strong first-day gains.
- Optimistic Future Outlook: With new filings from companies like SpaceX, more IPO transactions are expected in the coming months as the market broadens, and strong returns alongside a solid pipeline set the stage for a busy IPO calendar ahead.
See More
Latest Rating Changes on Wall Street
- Executive Rating Updates: Goldman Sachs initiates coverage on HawkEye 360 with a Buy rating, emphasizing its status as a profitable RF signals intelligence satellite operator, which is expected to achieve substantial revenue and earnings growth, reflecting strong confidence in its market potential.
- Dell Rating Upgrade: Morgan Stanley upgrades Dell from Underweight to Equal Weight, admitting prior market expectations were incorrect, highlighting Dell's superior supply chain management and execution compared to peers, enabling effective capture of critical demand and market share gains.
- MedTech Company Upgrade: Wells Fargo upgrades Tandem Diabetes Care to Overweight, citing an attractive risk/reward profile in the medical technology sector, indicating optimism about its future growth potential.
- Microsoft Market Performance Initiation: Citizens initiates Microsoft with a Market Outperform rating and a $550 price target, reflecting strong market performance potential despite a 7% decline year-to-date, indicating resilience in its business model.
See More
Suja Life Receives Bullish Ratings After IPO Quiet Period
- Wall Street Bullish Ratings: Suja Life (SUJA) received a clean sweep of bullish ratings from Wall Street after the IPO quiet period ended, with Goldman Sachs issuing a Buy rating and a price target of $31, reflecting strong market confidence in its growth potential.
- New Growth Vector in Functional Beverages: Jefferies analyst noted that juice is being reframed around functional benefits and convenient formats, creating a new growth vector within a $19 billion category, positioning Suja Life favorably as distribution expands and multipacks grow.
- Valuation Advantage: Gajrawala highlighted that Suja Life trades at a valuation of 13X the 2027 EBITDA estimate, which is a discount compared to high-growth peers, indicating its competitive edge and attractiveness in the market.
- Strong Market Performance: Shares of Suja Life (SUJA) jumped 6.9% in premarket trading to $16.50, approaching the IPO price of $21, demonstrating investor optimism regarding its future development.
See More
